The price of independence

British Medical Journal

Volumn 332, Issue 7555, 2006, Pages 1447-1449

  Collier, Joe ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CAREER; CONFLICT OF INTEREST; EDITOR; HUMAN; INDEPENDENCE; MEDICAL LITERATURE; MEDICAL PERSONNEL; NOTE; PHYSICIAN; PRIORITY JOURNAL; PUBLICATION; ARTICLE; DECISION MAKING; EPIDEMIOLOGY; PUBLISHING;

BIAS (EPIDEMIOLOGY); CONFLICT OF INTEREST; DECISION MAKING; EDITORIAL POLICIES; PERIODICALS;

EID: 33745289460     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.332.7555.1447     Document Type: Note

References (6)

1. Thymoxamine (Opilon). Drug and Therapeutics Bulletin 1969;7:99-100.
2. European Medicines Agency. EMEA procedure on the handling of conflicts of interests for EMEA scientific committee members and experts (EMEA/5475/04/Final). www.emea.eu.int/pdfs/general/direct/conflicts/ PolicyHandling ofConflictsofInterests.pdf (accessed 25 May 2006).
3. Chatham House. The Chatham House rule. http://www.chathamhouse. org.uk/index.php?id=14 (accessed 25 May 2006).
4. First report of the committee on standards of public life. London: Stationery Office, 1996.
5. Wise MEJ. Where expert witnesses fear to tread. BMJ 2006;332:500-1.
6. Boseley S. NHS will pay for breast cancer drug promises Hewitt. Guardian 2005 Oct 6.